Kathryn Schuff is an Endocrinology/Metabolic physician affiliated with Oregon Health & Science University. OpenAlex indexes 43 publications with 18,267 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Portland, OR 972393011
Telephone
503-494-3273Registry record last updated 10 Jul 2007.
Clinical trials
- Molecular Markers in Thyroid Cancer
Sponsor: OHSU Knight Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
88.8%l-Thyroxine77.6%Levothyroxine Sodium83%Synthroid17%Part D<11 patientsRecombinant Human Growth Hormone11.2%Omnitrope100%Part D<11 patientsMetabolism & gastrointestinal
11.2%Vitamin D3 Analog11.2%Calcitriol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1996–2001 per NIH RePORTER. The latest:
- CHARACTERIZATION OF GONADOTROPIN SECRETING CELL LINES
Oregon Health and Science University
FY2001$75,482R03DK056803 - MOLECULAR MECHANISMS OF HFSH/B GENE REGULATION
Oregon Health and Science University
FY2000$121,770K08DK002477 - CHARACTERIZATION OF GONADOTROPIN SECRETING CELL LINES
Oregon Health and Science University
FY2000$75,497R03DK056803
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Profound Hypothyroidism 21 Days After Methimazole Initiation in a Patient With Graves’s Disease and Liver Cirrhosis
Journal of the Endocrine Society
2021 - Cancer center support forunderstanding statewide COVID-19 prevalence and earlydetection
Clinical Cancer Research
2020 - Abstract PO-057: Cancer center support for understanding statewide COVID-19 prevalence and early detection
Clinical Cancer Research
2020 - Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects
The Journal of Clinical Endocrinology & Metabolism
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”